Zhou L - Search Results

1

Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors.

Qiao G, Wang X, Zhou X, Morse MA, Wu J, Wang S, Song Y, Jiang N, Zhao Y, Zhou L, Zhao J, Di Y, Zhu L, Hobeika A, Ren J, Lyerly HK. Qiao G, et al. Among authors: zhou x, zhou l. Int J Hyperthermia. 2019 Nov;36(sup1):74-82. doi: 10.1080/02656736.2019.1647350. Int J Hyperthermia. 2019. PMID: 31795830 Free article. Clinical Trial.

2

Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study.

Qiao G, Wang X, Zhou L, Zhou X, Song Y, Wang S, Zhao L, Morse MA, Hobeika A, Song J, Yi X, Xia X, Ren J, Lyerly HK. Qiao G, et al. Among authors: zhou x, zhou l. Clin Cancer Res. 2019 Mar 1;25(5):1494-1504. doi: 10.1158/1078-0432.CCR-18-2360. Epub 2018 Dec 4. Clin Cancer Res. 2019. PMID: 30514775

3

Prospective randomized comparative study on rivaroxaban and LMWH for prophylaxis of post-apheresis thrombosis in adoptive T cell immunotherapy cancer patients.

Wang X, Wang S, Morse MA, Jiang N, Zhao Y, Song Y, Zhou L, Huang H, Zhou X, Hobeika A, Ren J, Lyerly HK. Wang X, et al. Among authors: zhou x, zhou l. J Thromb Thrombolysis. 2019 May;47(4):505-511. doi: 10.1007/s11239-019-01844-7. J Thromb Thrombolysis. 2019. PMID: 30903459 Clinical Trial.

4

Serial assessment of circulating T lymphocyte phenotype and receptor repertoire during treatment of non-muscle invasive bladder cancer with adoptive T cell immunotherapy.

Wang X, Qiao G, Jiang N, Morse MA, Zhou X, Wang S, Wu J, Song Y, Zhao Y, Zhou L, Yuan Y, Hobeika A, Ren J, Lyerly HK. Wang X, et al. Among authors: zhou x, zhou l. Am J Cancer Res. 2021 Apr 15;11(4):1709-1718. eCollection 2021. Am J Cancer Res. 2021. PMID: 33948384 Free PMC article.

5

Four-and-a-half LIM protein 1 promotes paclitaxel resistance in hepatic carcinoma cells through the regulation of caspase-3 activation.

Zhou L, Ding L, Liu J, Zhang Y, Luo X, Zhao L, Ren J. Zhou L, et al. J Cancer Res Ther. 2018 Sep;14(Supplement):S767-S773. doi: 10.4103/0973-1482.187304. J Cancer Res Ther. 2018. PMID: 30249901 Free article.

6

Low-dose ionizing radiation induces direct activation of natural killer cells and provides a novel approach for adoptive cellular immunotherapy.

Yang G, Kong Q, Wang G, Jin H, Zhou L, Yu D, Niu C, Han W, Li W, Cui J. Yang G, et al. Among authors: zhou l. Cancer Biother Radiopharm. 2014 Dec;29(10):428-34. doi: 10.1089/cbr.2014.1702. Cancer Biother Radiopharm. 2014. PMID: 25402754 Free PMC article.

7

Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.

Cheng X, Wu D, Xu N, Chen L, Yan Z, Chen P, Zhou L, Yu J, Cui J, Li W, Wang C, Feng W, Wei Y, Yu P, Du Y, Ying J, Xu Z, Yang L, Zhang Y. Cheng X, et al. Among authors: zhou l. BMC Cancer. 2021 Jan 12;21(1):56. doi: 10.1186/s12885-020-07772-7. BMC Cancer. 2021. PMID: 33435909 Free PMC article.

8

A novel engineered interferon-α hybrid molecule increases anticancer efficacy of doxorubicin in breast cancer chemotherapy.

Li SJ, Liu CS, Li HJ, Li Y, Zhou L, Li JC, Chen YC, Su TQ, Yu DH. Li SJ, et al. Among authors: zhou l. Int J Oncol. 2017 Sep;51(3):949-958. doi: 10.3892/ijo.2017.4062. Epub 2017 Jul 3. Int J Oncol. 2017. PMID: 28677808

9

A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors.

Wang T, Wang D, Yu H, Feng B, Zhou F, Zhang H, Zhou L, Jiao S, Li Y. Wang T, et al. Among authors: zhou f, zhou l. Nat Commun. 2018 Apr 18;9(1):1532. doi: 10.1038/s41467-018-03915-4. Nat Commun. 2018. PMID: 29670088 Free PMC article.

10

Identification of immune subtypes to guide immunotherapy and targeted therapy in clear cell renal cell carcinoma.

Xu C, Li Y, Su W, Wang Z, Ma Z, Zhou L, Zhou Y, Chen J, Jiang M, Liu M. Xu C, et al. Among authors: zhou y, zhou l. Aging (Albany NY). 2022 Sep 1;14(17):6917-6935. doi: 10.18632/aging.204252. Epub 2022 Sep 1. Aging (Albany NY). 2022. PMID: 36057262 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,866 results

Search Page

Filters